Furthermore, a H-T-M-P-D (Herb-Target-Metabolite-Pathway-Disease) network analysis of the synergistic mechanism of CRP for preventing and treating NAFLD was shown in Figure 7B. This evidence concerns the gene CRP and metabolic dysfunction-associated steatotic liver disease.